• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Rhinoclir
    / Perrigo


    Active Ingredient

    Status in Israel
    OTC

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Nasal Spray

    30 ml

    not in the basket chart 88154

    Dosage

    2-3 sprays in each nostril, twice a day, in the morning and in the evening.


    Indications

    Relief of nasal congest.


    Contra-Indications

    Hypersensitivity, concurrent use with monoamine oxidase inhibitors, or within 10 days of discontinuing such therapy.
    See package insert (OTC).


    Special Precautions

    Infants and the elderly, pregnancy and lactation, coronary artery disease, hypertension, hyperthyroidism, diabetes mellitus.
    See package insert (OTC).


    Side Effects

    Local burning or stinging, dryness of the nasal mucosa, headache, insomnia, palpitations, trembling, sweating and nervousness. Prolonged use may cause rebound congestion and rhinorrhea.
    See package insert (OTC).


    Manufacturer
    Perrigo (USA)
    CLOSE